Clinical trial
Impact of the Use of Nandrolone on the Treatment of Malnutrition Induced by Cancer
NCT03263520 is registered in ClinicalTrials.gov with Hospital Erasto Gaertner as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of the Use of Nandrolone on the Treatment of Malnutrition Induced by Cancer
- Lead sponsor
- Hospital Erasto Gaertner
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 29, 2016
- Completion date
- October 31, 2017
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cachexia; cancer